Preparation and applications of organo-silica hybrid mesoporous silica nanoparticles for the co-delivery of drugs and nucleic acids

Iris Pontón, Andrea Martí del Rio, Marta Gómez Gómez, David Sánchez-García

Producció científica: Article en revista indexadaArticle de revisió (sistemàtica)Avaluat per experts

15 Cites (Scopus)

Resum

Combination therapies rely on the administration of more than one drug, with independent mechanisms of action, aiming to enhance the efficiency of the treatment. For an optimal performance, the implementation of such therapies requires the delivery of the correct combination of drugs to a specific cellular target. In this context, the use of nanoparticles (NP) as platforms for the co-delivery of multiple drugs is considered a highly promising strategy. In particular, mesoporous silica nanoparticles (MSN) have emerged as versatile building blocks to devise complex drug delivery systems (DDS). This review describes the design, synthesis, and application of MSNs to the delivery of multiple drugs including nucleic acids for combination therapies.

Idioma originalAnglès
Número d’article2466
Pàgines (de-a)1-37
Nombre de pàgines37
RevistaNanomaterials
Volum10
Número12
DOIs
Estat de la publicacióPublicada - de des. 2020

Fingerprint

Navegar pels temes de recerca de 'Preparation and applications of organo-silica hybrid mesoporous silica nanoparticles for the co-delivery of drugs and nucleic acids'. Junts formen un fingerprint únic.

Com citar-ho